高级检索
    陈双刚, 范卫君, 杨翼帆. 评TACTICS试验: TACE联合索拉非尼与单纯TACE在不可切除肝细胞癌中的对比研究[J]. 循证医学, 2021, 21(6): 332-336. DOI: 10.12019/j.issn.1671-5144.2021.06.004
    引用本文: 陈双刚, 范卫君, 杨翼帆. 评TACTICS试验: TACE联合索拉非尼与单纯TACE在不可切除肝细胞癌中的对比研究[J]. 循证医学, 2021, 21(6): 332-336. DOI: 10.12019/j.issn.1671-5144.2021.06.004
    shu
    CHEN Shuang-gang, FAN Wei-jun, YANG Yi-fan. Comment on the TACTICS Trial: A Comparative Study of TACE Combined With Sorafenib and TACE Alone in Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 332-336. DOI: 10.12019/j.issn.1671-5144.2021.06.004
    Citation: CHEN Shuang-gang, FAN Wei-jun, YANG Yi-fan. Comment on the TACTICS Trial: A Comparative Study of TACE Combined With Sorafenib and TACE Alone in Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 332-336. DOI: 10.12019/j.issn.1671-5144.2021.06.004
    shu

    评TACTICS试验: TACE联合索拉非尼与单纯TACE在不可切除肝细胞癌中的对比研究

    Comment on the TACTICS Trial: A Comparative Study of TACE Combined With Sorafenib and TACE Alone in Hepatocellular Carcinoma

      摘要
      • HTML全文
      • 参考文献(8)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回